Stock ISRG INTUITIVE SURGICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
375.3 USD +0.59% Intraday chart for Intuitive Surgical, Inc. +2.45% +11.26%
Apr. 26 Intuitive Elects Lewis Chew as Board of Directors CI
Apr. 24 Intuitive Surgical Insider Sold Shares Worth $741,398, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 68,321 96,172 128,355 93,771 118,775 133,132 - -
Enterprise Value (EV) 1 67,154 94,550 127,064 92,189 116,025 127,939 125,379 122,062
P/E ratio 51.2 x 92.8 x 77.1 x 72.7 x 67.1 x 68.1 x 59.3 x 49.7 x
Yield - - - - - - - -
Capitalization / Revenue 15.3 x 22.1 x 22.5 x 15.1 x 16.7 x 16.6 x 14.3 x 12.5 x
EV / Revenue 15 x 21.7 x 22.3 x 14.8 x 16.3 x 15.9 x 13.5 x 11.4 x
EV / EBITDA 35 x 54.6 x 48.4 x 37.1 x 41.2 x 41.3 x 34 x 28.1 x
EV / FCF 57.3 x 82.7 x 73.2 x 96.2 x 155 x 59.5 x 52.2 x 38.6 x
FCF Yield 1.75% 1.21% 1.37% 1.04% 0.65% 1.68% 1.92% 2.59%
Price to Book 8.3 x 8.62 x 10.8 x 8.41 x 9.06 x 8.36 x 6.69 x 5.56 x
Nbr of stocks (in thousands) 346,721 352,666 357,237 353,385 352,072 354,706 - -
Reference price 2 197.0 272.7 359.3 265.4 337.4 375.3 375.3 375.3
Announcement Date 1/23/20 1/21/21 1/20/22 1/24/23 1/23/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,478 4,358 5,710 6,222 7,124 8,026 9,304 10,681
EBITDA 1 1,920 1,732 2,625 2,487 2,819 3,098 3,692 4,340
EBIT 1 1,785 1,515 2,315 2,149 2,397 2,645 3,166 3,752
Operating Margin 39.85% 34.75% 40.54% 34.53% 33.65% 32.95% 34.03% 35.13%
Earnings before Tax (EBT) 1 1,502 1,207 1,890 1,607 1,959 2,223 2,673 3,114
Net income 1 1,379 1,061 1,705 1,322 1,798 1,961 2,267 2,661
Net margin 30.8% 24.33% 29.85% 21.25% 25.24% 24.43% 24.37% 24.91%
EPS 2 3.847 2.940 4.660 3.650 5.030 5.512 6.325 7.558
Free Cash Flow 1 1,173 1,143 1,736 958.4 749.6 2,149 2,402 3,162
FCF margin 26.18% 26.23% 30.4% 15.4% 10.52% 26.77% 25.81% 29.61%
FCF Conversion (EBITDA) 61.06% 66.03% 66.12% 38.54% 26.59% 69.36% 65.04% 72.87%
FCF Conversion (Net income) 85.01% 107.8% 101.84% 72.48% 41.69% 109.6% 105.94% 118.85%
Dividend per Share 2 - - - - - - - -
Announcement Date 1/23/20 1/21/21 1/20/22 1/24/23 1/23/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,551 1,488 1,522 1,557 1,655 1,696 1,756 1,744 1,928 1,891 1,969 1,991 2,172 2,173 2,277
EBITDA 1 668.8 611 611 636.5 628.4 627.4 709.9 732.3 744.2 734.2 757.4 784.7 839 831.2 895.3
EBIT 1 587.9 533.2 531.2 554.6 529.8 534.7 617.6 623.7 621 630 647.9 666.6 702 734.7 781.6
Operating Margin 37.91% 35.84% 34.9% 35.61% 32.01% 31.52% 35.17% 35.77% 32.2% 33.32% 32.9% 33.47% 32.33% 33.82% 34.33%
Earnings before Tax (EBT) 1 454.2 402.4 406.9 402.8 394.7 421.8 499.2 522 515.9 538.5 556.7 561.3 596 619 660.7
Net income 1 380.6 365.6 307.8 324 324.9 355.3 420.8 415.7 606.2 544.9 458.6 462.9 497.1 507.2 534.7
Net margin 24.54% 24.57% 20.22% 20.8% 19.63% 20.95% 23.96% 23.84% 31.44% 28.82% 23.29% 23.25% 22.89% 23.35% 23.49%
EPS 2 1.040 1.000 0.8500 0.9000 0.9100 1.000 1.180 1.160 1.690 1.510 1.288 1.300 1.380 1.426 1.516
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 1/20/22 4/21/22 7/21/22 10/18/22 1/24/23 4/18/23 7/20/23 10/19/23 1/23/24 4/18/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 1,168 1,623 1,291 1,581 2,750 5,193 7,753 11,070
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 1,173 1,143 1,736 958 750 2,149 2,402 3,162
ROE (net income / shareholders' equity) 20.4% 13.6% 16.8% 14.7% 14.7% 14.7% 14.6% 14.3%
ROA (Net income/ Total Assets) 17.4% 11.7% 14.7% 13.2% 12.7% 12.8% 12.9% 12.7%
Assets 1 7,949 9,065 11,607 9,995 14,208 15,377 17,573 20,931
Book Value Per Share 2 23.70 31.60 33.30 31.50 37.20 44.90 56.10 67.60
Cash Flow per Share 2 4.460 4.110 5.710 4.120 5.080 8.270 9.190 10.60
Capex 1 426 342 354 532 1,064 1,095 1,023 1,021
Capex / Sales 9.5% 7.84% 6.19% 8.56% 14.94% 13.64% 10.99% 9.56%
Announcement Date 1/23/20 1/21/21 1/20/22 1/24/23 1/23/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
375.3 USD
Average target price
420.3 USD
Spread / Average Target
+11.98%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
RESMED, INC. Stock ResMed, Inc.
+26.76% 32.03B
ILLUMINA, INC. Stock Illumina, Inc.
-12.18% 19.47B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ISRG Stock
  4. Financials Intuitive Surgical, Inc.